A Minimal Information Model for Potential Drug-Drug Interactions

• Egile Nagusiak: Harry Hochheiser (Egilea), Xia Jing (Egilea), Elizabeth A. Garcia (Egilea), Serkan Ayvaz (Egilea), Ratnesh Sahay (Egilea), Michel Dumontier (Egilea), Juan M. Banda (Egilea), Oya Beyan (Egilea), Mathias Brochhausen (Egilea), Evan Draper (Egilea), Sam Habiel (Egilea), Oktie Hassanzadeh (Egilea), Maria Herrero-Zazo (Egilea), Brian Hocum (Egilea), John Horn (Egilea), Brian LeBaron (Egilea), Daniel C. Malone (Egilea), Øystein Nytrø (Egilea), Thomas Reese (Egilea), Katrina Romagnoli (Egilea), Jodi Schneider (Egilea), Louisa (Yu) (Egilea), Richard D. Boyce (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Despite the significant health impacts of adverse events associated with drug-drug interactions, no standard models exist for managing and sharing evidence describing potential interactions between medications. Minimal information models have been used in other communities to establish community con...